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Introduction
Consistent evidence has been published showing the effectiveness of psychodynamic psychotherapy (PDT) with effect sizes similar to "empirically supported" psychotherapy approaches. [1] [2] [3] PDT aims to go beyond a mere reduction of symptoms and instead furnish patients with a better understanding of the sources of personal, interpersonal, and professional difficulties. [4] [5] [6] [7] Several studies have investigated which factors of the psychotherapy process have an influence on treatment effectiveness and how PDT outcomes can be reliably measured using various instruments. [4] [5] [6] [7] [8] [9] According to Brown, Scholle, and Azur, 10 measurements taken throughout PDT help identify potential dropouts.
Additionally, feedback has a positive effect on treatment outcomes.
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However, at present, no thorough guidelines exist with regards to the appropriate time during treatment for measuring each of the process and outcome factors.
This issue is very important, considering the importance of defining the appropriate dose of psychotherapy, since this information could be used to define protocols for public health authorities and private insurance companies.
Clinical trials have shown that in carefully controlled and implemented treatments between 57.6% and 67.2% of patients improve in an average of 12.7 sessions. Further, research on the dose-effect relationship of psychotherapy has shown that 11 to 21 sessions would be necessary for at least 50% of patients to recover. 12, 13 Other studies have described a dosage model of psychotherapeutic effectiveness that demonstrates a linear relationship between the number of sessions and the probability of patient improvement (log-normal dose). 14 Fifty percent of a sample showed reliable improvement by session 6, 60% by session 10, 69% by session 26, and 74% by session 52.
14 However, naturalistic data from a nationwide database of over 6,000 patients revealed that the average patient actually received fewer than five sessions. The rate of improvement in that sample was only about 20%.
These results suggest that, on average, patients do not get adequate doses of psychotherapy and that the recovery process is jeopardized as a consequence.
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Barrett, Chua, Crits-Christoph, Gibbons, and Thompson found that a mere 50% of patients who scheduled
an initial appointment at an outpatient clinic actually attended and, after intake, only 20% completed more than three sessions. are fostered through refinement of meta-reflective abilities. 4, 17 As part of the process, the patient may go through a phase during which they become unsettled and symptoms appear to worsen. This is to be expected and may necessarily precede resolution of the internal conflicts that originally drove the patient to seek therapy. The whole process is potentially non-linear and complex, which makes it all the more important to establish the appropriate time at which to evaluate the patient's progress. 18 Considering models of the stages of psychotherapy, we found the Hill three-phase model. 19 The Another model is based on the concept of "illness,"
which has three components: feeling ill, showing symptoms, and suffering from a functional disability. 14, 19 This model emphasizes empathy, collaboration with the patient throughout therapy, cultural considerations, and taking into account the needs of the individual patient.
The illness model presents a three-phase conception of the healing process, as follows: 1) remoralization, the enhancement of well-being, which is usually accomplished within a few sessions; 2) remediation, the attainment of symptomatic relief, which is accomplished more gradually; and 3) rehabilitation, the unlearning of troublesome, maladaptive, long-standing behavior and the establishing of new ways of dealing with various aspects of life, which is the final phase. 20, 21 Given that treatment has these different models and phases, it is relevant to follow the patient's progress through therapy by identifying which phase of therapy they have reached. 
Method Setting
Our longitudinal and naturalistic study was During the initial interview, patients were invited to participate in the study and given instructions. The clinic's adherence to PDT was the subject of a previous study.
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Participants
The study enrolled 304 adult patients who initiated PDT from April 2015 to May 2016 and 51 therapists who agreed to participate in the study. Most of the patients were women (66%, vs. 34% men). With respect to ethnicity, 83% of patients were white, 10% were multiracial, and 7% were black. The mean age was 32.6 years (± 10.3), and 77% had higher education.
Personal income was measured in multiples of the minimum wage (MW) and 33% of participants earned 4 to 6 times the MW, 32% earned 1 to 3 times the MW, 25% earned 7 or more times the MW, and 10% earned less than the MW. Regarding marital status, 63% were single and 37% were married. At screening, the main diagnostic hypotheses were mood disorder (40%) and anxiety disorder (40%), followed by adult personality disorders and behavioral disorders (10%), mental and behavioral disorders due to psychoactive substance use (5%), and behavioral syndromes associated with physiological disturbances and physical factors (5%).
The main reasons for seeking therapy were depressive problems (47%), anxiety problems (33%), avoidant personality problems (10%), antisocial personality problems (8%), and somatic problems (2%). Most of the therapists participating in this study were women (92%), and their mean age was 34.5 years (± 9.8).
Regarding academic training, 20 of the therapists (40%) had five or more years of PDT experience at the clinic, 15 (31%) had one year's experience, 8 (16%) had two years' experience, and 8 (13%) had three years' experience. Each therapist had an average of 5.67 (SD=3.64) patients.
Instruments
Clinical and sociodemographic questionnaire
Data reported by the patients were collected from a baseline assessment instrument completed by the patients and from notes taken by professionals during the intake interviews.
Symptom Checklist-90-Revised (SCL-90-R)
This instrument assesses nine dimensions of 
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Outcome Questionnaire (OQ-45) This instrument was developed to take repeated measures of a patient's progress in psychotherapy. 28 The questionnaire comprises a 45-item self-report scale with which patients rate their functioning over the past week on a five-point Likert scale ranging from "never" 
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The SCL-90-R and OQ-45 were administered again Following general convention, 33 an effect size of 0.20 was considered to be a small effect, 0.40 a moderate effect, and 0.80 a large effect.
Ethical considerations
The present study was approved by the ethics committee responsible for medical research where the study was conducted (CAAE 43011815.4.0000.5347).
All international standards for research involving human subjects were followed. To avoid interference in the therapeutic process, therapists and patients were not involved in the data collection procedures. The patients were informed about their right to withdraw from the study, voluntary participation, and potential risks and benefits. Patients who agreed to participate (signing informed consent after the research goals and methods had been fully explained) comprised the study sample.
Results
Results are presented starting with the process factor (therapeutic alliance), followed by outcome The flowchart illustrating participation and attrition is presented below (Figure 1 ).
Process factor: therapeutic alliance
With regard to the therapeutic alliance inventory (WAI), there were statistically significant differences between the perceptions of patients and therapists in the tasks (p = 0.001) and goals (p < 0.001) dimensions and also in total scores (p = 0.002). There were no significant differences in the bond dimension (p = 0.184) (Table 1) . Therefore, at the time of measurement, despite a similar perception of bond, patients and therapists disagreed on what the focus of therapy (goals) should be and on what should be done to achieve treatment goals (tasks). Patients tended to rate the therapeutic alliance higher than therapists (total score).
Outcome factors: symptoms and treatment progress Table 2 shows a comparison of the OQ-45 subscales at three time points (pre-treatment/screening, after 12 treatment sessions, and after 24 treatment sessions).
There were statistically significant differences in the overall score between time points 1 and 2, and the effect size was moderate. An improvement in symptoms was observed from pre-treatment to 12 sessions of treatment and was maintained after 24 sessions of treatment. There was no additional improvement from 12 sessions to 24 sessions. Table 3 shows a comparison of SCL-90-R dimensions at the three time points. There were statistically significant differences between time points 1 and 2 for most dimensions and the effect size was moderate.
There was a decrease in symptoms from pre-treatment 
Discussion
Although interpreting these data is difficult therapists but also phenomena involving the pair in a process that by definition is not necessarily linear. [34] [35] [36] It is essential to know the minimum time required to evaluate different outcomes to establish adequate protocols for treatments in different settings, an issue that is particularly relevant for public health authorities and private insurance providers.
In the alliance assessment, patients gave better evaluations than therapists on the goals dimension (negotiation and agreement on therapy goals in terms of outcomes) and on the task dimensions (specific activities developed by the pair to foster changes), while there was no significant difference on the bond dimension (interpersonal relations between patient and therapist).
These results may be an indication that therapists prioritize development of the analytical relationship (bond) in the early sessions before establishing goals and tasks and that the bond is established sooner than more "complex" aspects of the therapeutic alliance.
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This explanation is consistent with these findings, which identified a difference in treatment goals between patients and therapists at the beginning of PDT.
Nevertheless, despite a difference in evaluation, both patients and therapists gave a positive evaluation of the therapeutic alliance in this study. This finding supports the idea that the difference in treatment goals and tasks may not be a negative factor but may be a stage in an unfinished process, suggesting that more than four sessions would be necessary in order for all aspects of the alliance to be developed. A study of patients' motivation and its association with psychopathological states and session outcomes found that assessing goals in an intermediate phase, between the seventh and the fifteenth session, resulted in more positive evaluations by both patients and therapists than assessments carried out after the first five sessions. 39 Our findings did not confirm our hypothesis that four sessions would be sufficient for the patient to evaluate process factors such as therapeutic alliance.
In Hill's three-phase model, for example, the initial stage of therapy is characterized by patients feeling hopeful about therapy, since they have initiated the help-seeking behaviors (the re-moralization stage). 19 The therapist should help the patient understand how the analytical work functions, developing a therapeutic bond and identifying complaints more accurately, so that these complaints are turned into psychotherapy goals and tasks. 40 We, therefore, believe that at four sessions, goals and tasks were being developed, but had not been finalized. There is no improvement, however, between 12 and After this period, all dimensions of the therapeutic alliance, especially the focus of the treatment, should be reassessed when progressing to the intermediate phase. 43 There are limitations to this study that should be considered. The study was conducted at a single 
